Filed: 2/17/2026ACC: 0001193125-26-053268
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $286.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$286.52M
Total AUM (reported)
20.67M
Total Shares
Allocation by class
COMMON STOCK$214.11M74.7%
COMMON STOCK CLASS A$72.41M25.3%
Portfolio Concentration
Top 3$153.70M53.6%
4–10$130.41M45.5%
11–25$2.42M0.8%
Top 3 weight
53.6%
Top 10 weight
99.2%
Voting Authority Distribution
Total shares with voting rights: 20.67M
Sole
Full voting authority
20.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
Nuvation Bio
SOLEShares8.08M
TypeSH
Market value$72.41M
25.27%
Sole
8.08M
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics Inc.
SOLEShares3.29M
TypeSH
Market value$41.19M
14.37%
Sole
3.29M
Shared
0.00
None
0.00
Beta Bionics Inc.
SOLEShares1.32M
TypeSH
Market value$40.10M
14.00%
Sole
1.32M
Shared
0.00
None
0.00
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$37.10M
12.95%
Sole
2.20M
Shared
0.00
None
0.00
Kestra Med Technologies Ltd
SOLEShares1.37M
TypeSH
Market value$36.43M
12.71%
Sole
1.37M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares1.33M
TypeSH
Market value$36.01M
12.57%
Sole
1.33M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares876.36K
TypeSH
Market value$7.91M
2.76%
Sole
876.36K
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares653.22K
TypeSH
Market value$6.38M
2.23%
Sole
653.22K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.43M
1.20%
Sole
843.75K
Shared
0.00
None
0.00
ImageneBio, Inc.
SOLEShares455.36K
TypeSH
Market value$3.14M
1.10%
Sole
455.36K
Shared
0.00
None
0.00
Replimune Group
SOLEShares248.67K
TypeSH
Market value$2.42M
0.84%
Sole
248.67K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Nuvation BioSOLE | Common Stock Class A | 8.08M | SH | $72.41M 25.27% | 8.08M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $41.19M 14.37% | 3.29M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.32M | SH | $40.10M 14.00% | 1.32M | 0.00 | 0.00 |
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $37.10M 12.95% | 2.20M | 0.00 | 0.00 |
Kestra Med Technologies LtdSOLE | Common Stock | 1.37M | SH | $36.43M 12.71% | 1.37M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | Common Stock | 1.33M | SH | $36.01M 12.57% | 1.33M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 876.36K | SH | $7.91M 2.76% | 876.36K | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 653.22K | SH | $6.38M 2.23% | 653.22K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.43M 1.20% | 843.75K | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $3.14M 1.10% | 455.36K | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 248.67K | SH | $2.42M 0.84% | 248.67K | 0.00 | 0.00 |